Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells |
| |
Authors: | Pia Larsson Niklas Bergh Emma Lu Erik Ulfhammer Mia Magnusson Karin Wåhlander Lena Karlsson Sverker Jern |
| |
Affiliation: | 1. The Wallenberg Laboratory for Cardiovascular Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 2. CVGI iMed, AstraZeneca R&D, M?lndal, Sweden 3. The Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Bruna str?ket 16, SE-413 45, Gothenburg, Sweden
|
| |
Abstract: | A reduced capacity for acute tissue-type plasminogen activator (t-PA) release is likely to be associated with an impaired endogenous defense against intravascular thrombosis. Efficient approaches to pharmacologically restore a defective t-PA release have been lacking, but recent observations suggest that histone deacetylase inhibitors (HDACis) enhance t-PA production in vitro. HDACis have diverse chemical structures and different HDAC-enzyme sub-class targeting. We here compared the effects of several clinically used HDACis on t-PA production in endothelial cells. Human umbilical vein endothelial cells were exposed to a panel of 11 different HDACis and t-PA mRNA and protein levels were quantified. All HDACis dose-dependently stimulated t-PA mRNA and protein expression with similar maximal efficacy but with different potencies. Already at low concentrations, the majority of inhibitors caused significant and sustained effects on t-PA production. In addition, selected HDACis were capable of normalizing t-PA production when suppressed by the inflammatory cytokine TNF-α. We conclude that HDACis targeting classical HDAC enzymes are powerful inducers of t-PA expression in cultured endothelial cells and could be promising candidates for pharmacological modulation of endogenous fibrinolysis in man. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|